FDA analysis affirms use of computational models in imaging trials
AuntMinnie
AUGUST 9, 2024
In silico imaging trials represent a viable source of regulatory evidence for imaging device evaluation, according to an analysis conducted by the U.S. Then, FFDM and DBT images were simulated using a physics-based Monte Carlo x-ray transport code. a clinician model). Read the full paper here.
Let's personalize your content